Morning Overview on MSN
Brain immunity appears to undergo a major overhaul in middle age
An NIH-funded study of 40 human postmortem hippocampal samples, spanning ages 20 to 95, has found that the brainās resident ...
Morning Overview on MSN
A fingernail-sized jellyfish can rewind its own cells and dodge death
A jellyfish that measures roughly 4.5 mm across, smaller than a human fingernail, can do something no other known animal ...
Clayface movie 2026 uses the DC villainās origin to dramatize CRISPR gene therapyās central unsolved problem: off-target ...
The data shows that the brain's primary immune cells decline from age 50 to 75 years and are replaced with elevated inflammatory signatures.
My Adventures with Superman Season 3 SDCC panel lands Friday, July 24, as the full cast discusses the final season just days ...
Harvard geneticist Dr. David Sinclair's OSK therapy (ER-100) enters human trials. Learn how cellular reprogramming could ...
Nearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies ...
Neuronal Stimulation Induces Dematuration of Adult NeuronsNearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy ...
Nearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies ...
A research team at Fujita Health University led by Professor Tsuyoshi Miyakawa has uncovered a novel mechanism of cellular ...
The rapid progression of genetic engineering, regenerative medicine, and pharmacology has positioned gene, cell, and ...
A new study reveals 8-chloroadenosine inhibits hepatocellular carcinoma by disrupting the ADAR1/PPARĪ³ lipid metabolism axis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results